Unbiased AI-powered news
Three people died after a rare hantavirus outbreak on the cruise ship MV Hondius. U.S. officials began public briefings on May 9, nearly a week after the World Health Organization confirmed cases.
The HillThree people died after a rare hantavirus outbreak on the cruise ship MV Hondius in the Atlantic Ocean. More than 140 passengers and crew members were on board when the ship left Argentina on April 1. Forty-one people are now being monitored for exposure, including the highest-risk passengers who are in specialized quarantine facilities in Atlanta and Nebraska.
U.S. officials did not give their first public briefing on the outbreak until May 9. The World Health Organization had confirmed hantavirus infections linked to the MV Hondius almost a week earlier. The CDC notified states that American passengers had returned from the ship before issuing a formal notice to clinicians, health departments and laboratories, which was not published until late last Friday.
Interim CDC leader Jay Bhattacharya told reporters on Friday that the risk to the general public remains extremely low. He said there are currently no cases of the Andes virus, the hantavirus causing this outbreak, in the United States. Bhattacharya added that the CDC’s coordination with federal, state and local health departments is ongoing and will continue until everyone potentially exposed is through their monitoring period, home and healthy.
David Fitter, incident manager for the CDC’s hantavirus response, said in a call with reporters on Wednesday that this is not a novel virus and it is a known virus. Experts say hantavirus rarely spreads among people and only with close contact over a period of time rather than casual interactions.
The CDC lost the permanent head of the Division of High-Consequence Pathogens, which includes hantavirus, in December.
The permanent director of the National Center for Emerging and Zoonotic Infectious Diseases, which leads CDC’s hantavirus response, departed, leaving a new acting director in place. Debra Houry, formerly CDC’s chief medical officer, said there has been significant turnover of senior scientific leaders at the CDC.
Houry was among three senior CDC leaders who resigned last August to protest the politicization of science at the agency under Health Secretary Robert F. Kennedy Jr. Career scientists at the CDC have been fired or left the agency. Glen Nowak, professor and Director of the Grady College Center for Health & Risk Communication at the University of Georgia, who spent 14 years as a top spokesperson for the CDC, said it’s very rarely the case that silence from public health agencies is a helpful and effective communication strategy.
He said the fact that it’s mainly been political appointees speaking shows the loss of agency expertise. Jay Bhattacharya was one of the most prominent critics of the Biden administration’s response to the COVID-19 pandemic and argued against many of the public health mitigation measures during the COVID-19 pandemic as being too heavy handed.
Nowak said when you want to have political officials commenting, regardless of their party affiliation, that's always going to be a challenge.
Single source — no framing comparison available.
upi.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, on Thursday. Manufactured by Merck, the pill inhibits PCSK9 and cut LDL levels by up to 60 percent in a 24-week trial of 2,912 participants. It carries a list price of $315 for a 30-day supply and will reach…
washingtonpost.comFlooding along the Guadalupe River has killed at least one person in central Texas. The same area recorded more than 130 deaths in flash floods last summer. Governor Greg Abbott confirmed the fatality in a Thursday update.
flipboard.comEli Lilly will pay $2.8 billion in cash to acquire AtaiBeckley, a developer of psychedelic treatments for mental health conditions. The deal includes up to $1 billion in additional milestone payments. It adds the target’s compounds to Lilly’s neuroscience programs.